DK128208B - Fremgangsmåde til fremstilling af 1,4-diensteroider af androstan- eller pregnanrækken med usubstitueret 3-stilling. - Google Patents
Fremgangsmåde til fremstilling af 1,4-diensteroider af androstan- eller pregnanrækken med usubstitueret 3-stilling.Info
- Publication number
- DK128208B DK128208B DK268871AA DK268871A DK128208B DK 128208 B DK128208 B DK 128208B DK 268871A A DK268871A A DK 268871AA DK 268871 A DK268871 A DK 268871A DK 128208 B DK128208 B DK 128208B
- Authority
- DK
- Denmark
- Prior art keywords
- diensteroids
- androstane
- unsubstituted
- preparation
- pregnane series
- Prior art date
Links
- QZLYKIGBANMMBK-UGCZWRCOSA-N 5α-Androstane Chemical compound C([C@@H]1CC2)CCC[C@]1(C)[C@@H]1[C@@H]2[C@@H]2CCC[C@@]2(C)CC1 QZLYKIGBANMMBK-UGCZWRCOSA-N 0.000 title 1
- 150000003128 pregnanes Chemical class 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
- A61K31/573—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone substituted in position 21, e.g. cortisone, dexamethasone, prednisone or aldosterone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
- A61K31/568—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol substituted in positions 10 and 13 by a chain having at least one carbon atom, e.g. androstanes, e.g. testosterone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
- A61K31/568—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol substituted in positions 10 and 13 by a chain having at least one carbon atom, e.g. androstanes, e.g. testosterone
- A61K31/5685—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol substituted in positions 10 and 13 by a chain having at least one carbon atom, e.g. androstanes, e.g. testosterone having an oxo group in position 17, e.g. androsterone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
- A61K31/568—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol substituted in positions 10 and 13 by a chain having at least one carbon atom, e.g. androstanes, e.g. testosterone
- A61K31/569—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol substituted in positions 10 and 13 by a chain having at least one carbon atom, e.g. androstanes, e.g. testosterone substituted in position 17 alpha, e.g. ethisterone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J1/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, not substituted in position 17 beta by a carbon atom, e.g. estrane, androstane
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J5/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J7/00—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J75/00—Processes for the preparation of steroids in general
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Steroid Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US54480066A | 1966-04-25 | 1966-04-25 | |
| US62246867A | 1967-03-13 | 1967-03-13 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| DK128208B true DK128208B (da) | 1974-03-18 |
Family
ID=27067737
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DK218567AA DK127727B (da) | 1966-04-25 | 1967-04-25 | Fremgangsmåde til fremstilling af et 1,4-diensteroid af androstan- eller pregnanrækken og med usubstitueret 3-stilling. |
| DK268871AA DK128208B (da) | 1966-04-25 | 1971-06-02 | Fremgangsmåde til fremstilling af 1,4-diensteroider af androstan- eller pregnanrækken med usubstitueret 3-stilling. |
Family Applications Before (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DK218567AA DK127727B (da) | 1966-04-25 | 1967-04-25 | Fremgangsmåde til fremstilling af et 1,4-diensteroid af androstan- eller pregnanrækken og med usubstitueret 3-stilling. |
Country Status (12)
| Country | Link |
|---|---|
| US (1) | US3574196A (da) |
| JP (1) | JPS495335B1 (da) |
| BE (1) | BE697544A (da) |
| CH (1) | CH538459A (da) |
| DE (1) | DE1618058B1 (da) |
| DK (2) | DK127727B (da) |
| ES (1) | ES339707A1 (da) |
| FR (2) | FR1529732A (da) |
| GB (2) | GB1192062A (da) |
| IL (1) | IL27840A (da) |
| NL (1) | NL6705803A (da) |
| SE (2) | SE342237B (da) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPS5135937U (da) * | 1974-09-06 | 1976-03-17 | ||
| JPS5135936U (da) * | 1974-09-06 | 1976-03-17 |
-
1967
- 1967-03-13 US US622468A patent/US3574196A/en not_active Expired - Lifetime
- 1967-04-21 IL IL27840A patent/IL27840A/en unknown
- 1967-04-24 GB GB63268/69A patent/GB1192062A/en not_active Expired
- 1967-04-24 ES ES339707A patent/ES339707A1/es not_active Expired
- 1967-04-24 CH CH578367A patent/CH538459A/de not_active IP Right Cessation
- 1967-04-24 GB GB08663/67A patent/GB1192061A/en not_active Expired
- 1967-04-25 JP JP42026076A patent/JPS495335B1/ja active Pending
- 1967-04-25 SE SE5833/67A patent/SE342237B/xx unknown
- 1967-04-25 DE DE1967A0055538 patent/DE1618058B1/de not_active Withdrawn
- 1967-04-25 DK DK218567AA patent/DK127727B/da unknown
- 1967-04-25 NL NL6705803A patent/NL6705803A/xx unknown
- 1967-04-25 SE SE17633/70A patent/SE362073B/xx unknown
- 1967-04-25 BE BE697544D patent/BE697544A/xx unknown
- 1967-04-25 FR FR104147A patent/FR1529732A/fr not_active Expired
- 1967-07-24 FR FR115422A patent/FR8354M/fr not_active Expired
-
1971
- 1971-06-02 DK DK268871AA patent/DK128208B/da unknown
Also Published As
| Publication number | Publication date |
|---|---|
| BE697544A (da) | 1967-10-02 |
| GB1192061A (en) | 1970-05-20 |
| DE1793749B2 (de) | 1975-07-24 |
| DE1793749A1 (de) | 1973-05-03 |
| ES339707A1 (es) | 1968-05-16 |
| NL6705803A (da) | 1967-10-26 |
| SE362073B (da) | 1973-11-26 |
| DE1618058B1 (de) | 1972-07-13 |
| IL27840A (en) | 1972-04-27 |
| FR1529732A (fr) | 1968-06-21 |
| US3574196A (en) | 1971-04-06 |
| SE342237B (da) | 1972-01-31 |
| FR8354M (da) | 1971-02-08 |
| JPS495335B1 (da) | 1974-02-06 |
| GB1192062A (en) | 1970-05-20 |
| CH538459A (de) | 1973-06-30 |
| DK127727B (da) | 1973-12-24 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DK121857B (da) | Analogifremgangsmåde til fremstilling af 11β-alkyloxy-13β-alkylgona-1,3,5,(10)-trienderivater. | |
| DK117896B (da) | Analogifremgangsmåde til fremstilling af 17-estere af 21-desoxyprednisolon. | |
| DK129835B (da) | Analogifremgangsmåde til fremstilling af 2-chlor-6α-fluor-16α-methyl-pregna-1,4-dien-3,20-dioner. | |
| DK136218B (da) | Analogifremgangsmåde til fremstilling af 3alfa-hydroxysteroider af pregnan- eller 19-norpregnanrækken. | |
| DK124680B (da) | Fremgangsmåde til fremstilling af 2'-substituerede steroid-[16α, 17α-d]-oxazoliner af pregnanrækken. | |
| DK128895B (da) | Fremgangsmåde til fremstilling af pregnanderivater. | |
| DK126111B (da) | Fremgangsmåde til fremstilling af Δ<5,10>-steroider med cyclopentanoperhydrophenanthrenstruktur. | |
| DK128208B (da) | Fremgangsmåde til fremstilling af 1,4-diensteroider af androstan- eller pregnanrækken med usubstitueret 3-stilling. | |
| DK120540B (da) | Fremgangsmåde til fremstilling af 17α-alkynyl-17β-acyloxysteroider af androstan- eller estranrækken. | |
| DK124539B (da) | Fremgangsmåde til fremstilling af 6-hydroxy-3-keto-Δ<1,4>-steroider af pregnan- eller androstanrækken. | |
| DK114060B (da) | Fremgangsmåde til fremstilling af terapeutisk virksomme 1,2β-metylensteroider af androstan- eller 9-norandrostanrækken. | |
| DK115472B (da) | Fremgangsmåde til fremstilling af 11-hydroxylerede steroider af pregnanrækken. | |
| DK129004B (da) | Analogifremgangsmåde til fremstilling af 9α-usubstituerede 11β-klor-19-norsteroider af østran- eller 19-norpregnanrækken. | |
| DK127420B (da) | Analogifremgangsmåde til fremstilling af 6α-fluor-16α,18-dimethyl-1,4-pregnadien-3,20-dionderivater. | |
| DK122275B (da) | Fremgangsmåde til fremstilling af 17α-ætynyl-17β-hydroksysteroider af androstan- eller østranrækken. | |
| DK119657B (da) | Fremgangsmåde til fremstilling af 17α-acyloxy-21-hydroxy-steroider af pregnanrækken. | |
| DK117420B (da) | Analogifremgangsmåde til fremstilling af 12-oxygeneret-Δ<3>-A-norandrosten-2,17-dion. | |
| DK132121B (da) | Fremgangsmåde til fremstilling af 17alfa-hydroxypregna-4,9(11)-dien-3,20-dion. | |
| DK126937B (da) | Fremgangsmåde til fremstilling af 4,6-dihalogen-16-alkyliden-17α-hydroxy-pregna-4,6-dien-3,20-dioner. | |
| DK120487B (da) | Fremgangsmåde til fremstilling af ætynylderivater af oxosteroider af pregnan-, østran- eller androstanrækken. | |
| DK118461B (da) | Fremgangsmåde til fremstilling af 6-halogen- eller -alkylsubstituerede 4-chlor-Δ<4,6>-steroiddiener af androstan- eller pregnanrækken. | |
| DK128239B (da) | Analogifremgangsmåde til fremstilling af 18-methylensteroider af pregnan- eller 19-nor-pregnanrækken. | |
| DK113639B (da) | Analogifremgangsmåde til fremstilling af 9α-flour-11β-hydroxypregna-1,4-dien-[17α,16α-d]-oxazolin-3,20-dioner. | |
| DK125644B (da) | Analogifremgangsmåde til fremstilling af 6-halogenpregna-4,6-dien-3,20-dion-[17α, 16α-d]-oxazoliner. | |
| DK121119B (da) | Analogifremgangsmåde til fremstilling af 6,6-dihalogen-3-oxo-Δ<4>-9β,10α-steroider af androstan- eller pregnanrækken. |